3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
66
Carcinoma, Renal Cell
38
Liver Neoplasms
20
Neoplasm Metastasis
17
Carcinoma, Non-Small-Cell Lung
16
Neoplasms
15
Breast Neoplasms
15
Melanoma
13
Thyroid Neoplasms
10
Leukemia, Myeloid, Acute
10
Sarcoma
9
Lung Neoplasms
8
Kidney Neoplasms
8
Prostatic Neoplasms
7
Ovarian Neoplasms
7
Urinary Bladder Neoplasms
6
Pancreatic Neoplasms
6
Glioblastoma
6
Brain Neoplasms
6
Colorectal Neoplasms
5
Carcinoma, Medullary
5
Thyroid Carcinoma, Anaplastic
4
Stomach Neoplasms
4
Rectal Neoplasms
4
Gliosarcoma
4
Gallbladder Neoplasms
4
Colonic Neoplasms
4
Breast Neoplasms, Male
4
Thyroid Diseases
3
Thyroid Cancer, Papillary
3
Interventions
Fluorouracil
37
Radiotherapy
31
Oxaliplatin
29
Cisplatin
28
Paclitaxel
24
Leucovorin
22
Irinotecan
19
Docetaxel
13
pembrolizumab
10
Capecitabine
10
Carboplatin
9
Radiation
8
Neoadjuvant Therapy
8
Cetuximab
8
Surgical Procedures, Operative
7
Folfox protocol
7
Chemotherapy, Adjuvant
6
Nivolumab
5
Gefitinib
5
Taxes
4
Erlotinib Hydrochloride
4
Biopsy
4
durvalumab
3
Panitumumab
3
Itraconazole
3
Epirubicin
3
Bevacizumab
3
tremelimumab
2
spartalizumab
2
ixabepilone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Adenocarcinoma Of Esophagus
×
Sorafenib
×
Clear all
NCT01158287
2014-12-31
Sorafenib. ICORG 06-41, V4
Cancer Trials Ireland
Phase 2
Completed
54 enrolled